Big Y and Bonum Health(TM) (TRxADE HEALTH Company) to deploy New Telemedicine Program

TAMPA, FL / ACCESSWIRE / July 1, 2021 / TRxADE HEALTH INC. (NASDAQ:MEDS) an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum Health, a Digital Healthcare business subsidiary has signed a Telemedicine Service Distribution Deal with Big Y Pharmacy and Wellness Centers within their supermarkets in Massachusetts and Connecticut.

Bonum Health will provide affordable telemedicine services to the patients of all Big Y pharmacies by offering Bonum Health’s signature Mobile Health Services and prescriber program, staffed by over 600 board-certified medical providers. The partnership also provides Big Y patients direct access to prescription discount savings through Bonum Health. The gap between uninsured and under-insured consumers across Massachusetts and Connecticut widens daily, and consumers are demanding easier access to affordable healthcare providers.

“Big Y wanted to expand our digital healthcare offerings and to enhance our collaborative care network. Bonum Health is a strategic partner that helps us diversify our in-store and community digital healthcare services. Their mobile application enables a turn-key Telemedicine and Prescriptions Savings tool to seamlessly integrate into our Big Y pharmacies,” stated Steve Nordstrom, Director of Center Store and Pharmacy.

Ashton Maaraba, President of Bonum Health noted, “We are thrilled and fortunate to team up with Big Y and their outstanding Health & Wellness leadership and in-store staff. Big Y pharmacy leadership recognized an opportunity to provide greater access to deeply discounted low-cost care to their patients, in combination with furthering their prescription discounts, under our unique digital platform, and Big Y chose Bonum Health. We are looking forward to serving each Big Y consumer household.”

About TRxADE HEALTH, INC.
TRxADE HEALTH (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 12,100+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For info on TRxADE HEALTH, please visit the Company’s IR website at investors.trxadegroup.com.

About Big Y Foods, Inc.
Big Y Foods, Inc. is one of the largest independently owned supermarket chains in New England. Big Y operates 84 locations throughout Massachusetts and Connecticut including 71 supermarkets, Fresh Acres Market, Table & Vine Fine Wines and Liquors and 10 Big Y Express gas and convenience locations with almost 12,000 employees. Big Y has been recognized by Forbes as a Best-in-State Employer in Massachusetts and Connecticut, as well as Employer of Choice by the Employers Association of the Northeast. Founded in 1936 by brothers Paul and Gerald D’Amour, the store was named after an intersection in Chicopee, Massachusetts where two roads converge to form a “Y”.

Forward-Looking Statements
This press release may contain forward-looking statements, including information about management’s view of TRxADE’s future expectations, plans and prospects, within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the “Act”). In particular, when used in the preceding discussion, the words “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions are intended to identify forward-looking statements within the meaning of the Act, and are subject to the safe harbor created by the Act. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of TRxADE, its divisions and concepts to be materially different than those expressed or implied in such statements. These risks include risks relating to the adoption of our MedCheks app by partners and end-users, the apps of other competitors, including governments which may make certain apps mandatory or free, our ability to gain traction for our app in the marketplace, and the continued demand for our app; risks related to our operations not being profitable; claims relating to alleged violations of intellectual property rights of others; our ability to monetize our technological solutions; technical problems with our websites, apps and products; risks relating to implementing our acquisition strategies; our ability to manage our growth; negative effects on our operations associated with the opioid pain medication health crisis; regulatory and licensing requirement risks; risks related to changes in the U.S. healthcare environment; the status of our information systems, facilities and distribution networks; risks associated with the operations of our more established competitors; regulatory changes; healthcare fraud; COVID-19, governmental responses thereto, economic downturns and possible recessions caused thereby; changes in laws or regulations relating to our operations; privacy laws; system errors; dependence on current management; our growth strategy; and others that are included from time to time in filings made by TRxADE with the Securities and Exchange Commission, including, but not limited to, in the “Risk Factors” sections in its Form 10-Ks and Form 10-Qs and in its Form 8-Ks, which it has filed, and files from time to time, with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov. Other unknown or unpredictable factors also could have material adverse effects on TRxADE’s future results and/or could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. TRxADE cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

Media Contact:
Simone Valdez
IR@trxade.com
(800) 261-0281

Investor Relations:
Lucas Zimmerman, Senior Vice President
MZ Group – MZ North America
(949) 259-4987 | MEDS@mzgroup.us | www.mzgroup.us

SOURCE: Trxade Group, Inc.

View source version on accesswire.com:
https://www.accesswire.com/653657/Big-Y-and-Bonum-HealthTM-TRxADE-HEALTH-Company-to-deploy-New-Telemedicine-Program